Transcript:
The Certara community and interdisciplinary industry experts and scientists from model and form drug development bio simulation, clinical pharmacology, regulatory science, and software development come together for Certainty. Certara’s first annual client summit. This coming May fourteenth through sixteenth in Philadelphia at Convene. We will unite to share future visions, strategies, industry trends, and best practices for accelerating modern drug development.
On day one, attendees will delve into either Phoenix, Pinnacle twenty one user groups, a workshop on mechanistic modeling or a roundtable discussion on Generative AI in regards to Medical Writing.
On day two, doctor Scott Gottlieb, former US FDA Commissioner, We’ll keynote the event with a fireside chat with Bill Feehery, Certara’s CEO on lessons learned to help advance medicine. The event continues with opportunities to network and learn about.
The business impact of biosimulation and MIDD by specific therapies, populations, and phases of development. Digital data flows and processes that streamline data insights from protocol design, through approvals.
And global regulatory submission processes and the impact of AI on regulatory sciences.
Companies, sharing case studies on these topics include AstraZeneca, Arcus, Genentech, GSK, and more. We look forward to seeing you at our inaugural Certainty event, where innovation, science, and collaboration converge to shape the future of drug development. Register now.
